Ovarian Cancer Drugs Market Size Worth USD 5.35 Billion in 2032 | Emergen Research
November 28, 2023 11:00 ET
|
Emergen Research
Vancouver, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global ovarian cancer drugs market is set to experience substantial expansion, reaching a size of USD 2.40 Billion in 2022 and projecting an...
IRBM Selected for Participation in National Chemical Biology Consortium
April 04, 2023 03:00 ET
|
IRBM
ROME, April 04, 2023 (GLOBE NEWSWIRE) -- IRBM, a drug discovery and early development research institute and global contract research organization, announces that it is joining the Chemical Biology...
Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST
March 23, 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 23, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a developer of Next Generation Chemotherapy drugs that provide a better...
Oncology Cancer Drugs Market Size is projected to reach USD 288 Billion by 2030, growing at a CAGR of 7.7%: Straits Research
August 15, 2022 15:50 ET
|
Straits Research
New York, United States, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cancer develops when the body's common control mechanism malfunctions and cannot stop the proliferation of abnormal cells. In this case,...
RAFA To Add Major Component to the Tashkent Pharma Park
December 17, 2021 11:34 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company “Block” signed an agreement on the implementation of the construction of a...
Cancer and Allied Advancements in Chemotherapy – Straits Research
September 16, 2021 09:00 ET
|
Straits Research
New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029. The global...
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
August 19, 2021 10:25 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
Oncology/Cancer Drugs Market to Reach $222.38 Bn by 2027 at 7.4% CAGR
April 20, 2021 08:40 ET
|
Allied Market Research
Portland, OR, April 20, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Oncology/Cancer Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy,...
Global PARP Inhibitor Market To Grow At A CAGR Of 27.4% Due To Expanding Role Of PARP Inhibitors In Cancer Treatment
July 22, 2020 08:30 ET
|
Quince Market Insights
Pune, India, July 22, 2020 (GLOBE NEWSWIRE) -- Global PARP Inhibitor Market was valued at USD 924 million in 2018 and predicted to grow at an exponential CAGR of 27.4% during the forecast period....
Celgene Rescinds Agreement to Compensate Cancer Patients Days Before Christmas
January 08, 2020 13:36 ET
|
Hausfeld
WASHINGTON, Jan. 08, 2020 (GLOBE NEWSWIRE) -- On December 23, 2019, Celgene backed out of a settlement in which it had agreed to pay $55 million to end payors (consumers, insurers, union health and...